Three drugmakers settle with California over deals to keep generic medications off the market

Three drugmakers settle with California over deals to keep generic medications off the market

by Samantha Masunaga

Teva maintained a monopoly over sales of a narcolepsy drug by entering “pay-for-delay” deals to delay a generic version for six years, Atty. Gen. Xavier Becerra’s office said.

All credit goes to Samantha Masunaga
Originally published on https://www.latimes.com/california/rss2.0.xml